Related Experiment Video
Updated: Apr 3, 2026

07:35
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
8.1K
Development of a diagnostic test based on multiple continuous biomarkers with an imperfect reference test
Leandro García Barrado1, Els Coart2, Tomasz Burzykowski1,2
1Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BioStat), Hasselt University, Agoralaan Building D, Diepenbeek, 3590, Belgium.
Statistics in Medicine
|September 22, 2015
Summary
This study introduces a Bayesian model to accurately select diagnostic biomarkers by accounting for imperfect reference tests. The new method improves diagnostic accuracy estimates, crucial for reliable disease detection.
Area of Science:
- Biostatistics
- Biomarker Discovery
- Diagnostic Accuracy
Background:
- Reference tests for biomarker accuracy can be imperfect, leading to biased diagnostic accuracy estimates.
- Accurate estimation of diagnostic accuracy is vital for selecting effective biomarker combinations.
Purpose of the Study:
- To propose a Bayesian latent-class mixture model for selecting biomarker combinations that maximize the area under the ROC curve (AUC).
- To develop a method for prior specification that controls information on AUC, accounting for imperfect reference tests.
Main Methods:
- A Bayesian latent-class mixture model was developed and evaluated using simulation studies.
- The model was applied to real-world data from Alzheimer's disease research.
- Prior specifications for mixture component parameters were investigated, including informative and flat priors.
Main Results:
- Simulation studies demonstrated satisfactory performance and accurate parameter estimates for the proposed model.
- The Bayesian model yielded substantially higher AUC estimates compared to traditional logistic regression models that ignore reference test imperfections.
- Model performance was evaluated across various sample sizes and biomarker correlations.
Conclusions:
- The proposed Bayesian model effectively addresses the challenge of imperfect reference tests in biomarker selection.
- This approach provides more reliable and higher diagnostic accuracy estimates than conventional methods.
- The model is valuable for biomarker research, particularly in complex diseases like Alzheimer's.

